Literature DB >> 24034264

Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.

Mylene T Truong1, Chitra Viswanathan, Myrna B C Godoy, Brett W Carter, Edith M Marom.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24034264     DOI： 10.1053/j.ro.2013.03.017

Source DB:  PubMed          Journal:  Semin Roentgenol        ISSN： 0037-198X            Impact factor:   0.800


× No keyword cloud information.
  8 in total

1.  Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment.

Authors:  Malgorzata Szolkowska; Katarzyna Blasinska-Przerwa; Magdalena Knetki-Wroblewska; Piotr Rudzinski; Renata Langfort
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Interobserver Variability of Quantitative and Qualitative Assessment Using MRI in Malignant Pleural Mesothelioma.

Authors:  Ritu R Gill; David J Murphy; Ravi T Seethamraju; Emanuele Mazzola; Raphael Bueno; William G Richards
Journal:  Radiol Cardiothorac Imaging       Date:  2020-04-30

Review 3.  New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.

Authors:  Anne S Tsao; Harvey I Pass; Andreas Rimner; Aaron S Mansfield
Journal:  J Clin Oncol       Date:  2022-01-05       Impact factor: 44.544

Review 4.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

5.  Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Hedy L Kindler; Nofisat Ismaila; Samuel G Armato; Raphael Bueno; Mary Hesdorffer; Thierry Jahan; Clyde Michael Jones; Markku Miettinen; Harvey Pass; Andreas Rimner; Valerie Rusch; Daniel Sterman; Anish Thomas; Raffit Hassan
Journal:  J Clin Oncol       Date:  2018-01-18       Impact factor: 44.544

6.  Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment.

Authors:  Cheng-Jun Ban; Huan-Zhong Shi; Yu-Hui Zhang
Journal:  Chin Med J (Engl)       Date:  2017 5th Jan 2017       Impact factor: 2.628

7.  Malignant Pleural Mesothelioma with Marked Lymphatic Involvement: A Report of Two Autopsy Cases.

Authors:  Reiko Ideguchi; Kazuto Ashizawa; Saori Akashi; Michiko Shindo; Kazunori Minami; Toshio Fukuda; Junji Irie; Minoru Fukuda; Masataka Uetani
Journal:  Case Rep Oncol Med       Date:  2017-05-29

Review 8.  Clinical staging of malignant pleural mesothelioma: current perspectives.

Authors:  Maria Bonomi; Costantino De Filippis; Egesta Lopci; Letizia Gianoncelli; Giovanna Rizzardi; Eleonora Cerchiaro; Luigi Bortolotti; Alessandro Zanello; Giovanni Luca Ceresoli
Journal:  Lung Cancer (Auckl)       Date:  2017-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.